Scribd Logo
Upload

Welcome to Scribd!

  • Online Activity Week 10: Cardiac Scanning

    Uploaded by

    Colleen
    8 views1 page
    The document discusses cardiac and liver scanning techniques. For cardiac scanning, left ventricular opacification was previously the main approved contrast imaging method, useful for delineating heart borders, but newer microbubble contrast agents now allow tracking red blood cell movement. For liver scanning, the FDA approved the first non-cardiac contrast agent called Lumason in 2016 for identifying liver lesions in pediatrics and adults, though parts of Asia have routinely used such techniques for longer.

    Original Description:

    Original Title

    Untitled

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document discusses cardiac and liver scanning techniques. For cardiac scanning, left ventricular opacification was previously the main approved contrast imaging method, useful for delineating heart borders, but newer microbubble contrast agents now allow tracking red blood cell movement. For liver scanning, the FDA approved the first non-cardiac contrast agent called Lumason in 2016 for identifying liver lesions in pediatrics and adults, though parts of Asia have routinely used such techniques for longer.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    8 views1 page

    Online Activity Week 10: Cardiac Scanning

    Uploaded by

    Colleen
    The document discusses cardiac and liver scanning techniques. For cardiac scanning, left ventricular opacification was previously the main approved contrast imaging method, useful for delineating heart borders, but newer microbubble contrast agents now allow tracking red blood cell movement. For liver scanning, the FDA approved the first non-cardiac contrast agent called Lumason in 2016 for identifying liver lesions in pediatrics and adults, though parts of Asia have routinely used such techniques for longer.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 1

    Online Activity Week 10

    Cardiac scanning
    Up until 2016 one of the only approved contrast imaging was left ventricular opacification (LVO).
    This id useful in the delineation of endocardial borders. As of today the current contrast agents
    consist different types of microbubbles. These are useful in tracking movement of RBCs in the
    heart.

    Liver scanning
    In 2016 the FDA approved the first agent for non cardiac application (for the United States). This
    was Lumason, it is used for the focalization of liver lesions for pediatrics and adults. However,
    compared to Asia focal liver lesion has been a routine practice for many years and is still being
    studied.

    You might also like